Imagen 1 de 1
Foto genérica
Imagen 1 de 1
Foto genérica
Skidmore Nursing Drug Reference Ser.: Mosby's 2023 Nursing Drug Reference by Linda Skidmore-Roth (2022, Trade Paperback)
A
anacristinababer (210)
100% de votos positivos
Precio:
USD26,00
Aproximadamente22,25 EUR
+ USD25,98 de envío
Devoluciones:
30 días para devoluciones. El comprador paga el envío de la devolución..
Estado:
The product is "Mosby's 2023 Nursing Drug Référence" by Linda Skidmore-Roth, part of the Skidmore Nursing Drug Référence Ser. Published by Elsevier-Health Sciences Division in 2022, this textbook is in trade paperback format and consists of 1504 pages. It is a comprehensive drug reference guide tailored for nursing professionals, covering subjects such as nursing, clinical medicine, drug guides, and pharmacology, all in English language. This textbook serves as an essential resource for nursing students and professionals seeking up-to-date information on medications and their usage in clinical practice.
- ¡Cómpralo ya!Skidmore Nursing Drug Reference Ser.: Mosby's 2023 Nursing Drug Reference by...
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Acerca de este artículo
Product Identifiers
PublisherElsevier-Health Sciences Division
ISBN-100323930727
ISBN-139780323930727
eBay Product ID (ePID)5050433219
Product Key Features
Number of Pages1504 Pages
LanguageEnglish
Publication NameMosby's 2023 Nursing Drug Reference
SubjectClinical Medicine, Drug Guides, Nursing / Reference, Nursing / Pharmacology
Publication Year2022
TypeTextbook
AuthorLinda Skidmore-Roth
Subject AreaMedical
SeriesSkidmore Nursing Drug Reference Ser.
FormatTrade Paperback
Additional Product Features
Edition Number36
Intended AudienceScholarly & Professional
Dewey Edition23
IllustratedYes
Dewey Decimal615.1
Table Of ContentINDIVIDUAL DRUG MONOGRAPHS APPENDIXES A. Selected New Drugs abametapir aducanumab-avwa afamelanotide anifrolumab-fnia asciminib atogepant avacopan avapritinib belumosudil belzutifan bempedoic acid brolucizumab-dbll difelikefalin dostarlimab-gxly eculizumab efavirenz/emtricitabine/tenofovir elapegademase-ivir elbasvir/grazoprevir elexacaftor/tezacaftor/ivacaftor and ivacaftor emtricitabine/rilpivirine/tenofovir alafenamide enalapril/hydrochlorothiazide ephedrine factor IX complex factor IX, human factor IX, recombinant finerenone fluocinolone fluocinonide lonapegsomatropin-tcgd loncastuximab tesirine-lpyl maribavir mobocertinib odevixibat ropeginterferon alfa-2b tisotumab vedotin-tftv vosoritide B. Ophthalmic, Nasal, Topical, and Otic Products C. Vaccines and Toxoids D. Recent FDA Drug Approvals INDEX EVOLVE WEBSITE . Additional Monographs . Drug Categories
SynopsisChoose the drug handbook trusted by nurses for more than 35 years! Mosby's 2023 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled - including 35 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on both common and life-threatening side effects. From nursing pharmacology expert Linda Skidmore-Roth, this perennial bestseller proves there is a difference in drug guides. More than 5,000 generic and trade-name drugs are profiled, covering almost every drug you will administer in practice or in clinicals. Safety Alert icon highlights the most critical drug interactions and side effects. Black Box Warnings provide alerts to FDA warnings of dangerous or life-threatening drug reactions. Nursing Process steps are used as the framework for organizing all nursing care information. Coverage of IV drug administration highlights dosage and IV administration instructions, including safety considerations and Y-site, syringe, and additive compatibilities. Side effects information is organized by body system and identified as common or life threatening, showing signs to watch for during assessments. Alphabetical organization by generic name provides quick and easy access to specific drugs, and a full-color design highlights important information. Complete pharmacokinetic information includes the mechanism and absorption of the drug as well as its action, duration, and excretion. Overview of drug categories explains the safe administration of common classes of drugs, as well as their common side effects and interactions. Flexible, water-resistant cover provides durability in the clinical setting. NEW! Drug monographs for 35 new FDA-approved medications equip you with the latest drug information including generic names, trade names, pronunciations, do-not-confuse drugs, action, uses, contraindications, precautions, dosages and routes, side effects, pharmacokinetics, interactions (including drug/herb, drug/food and drug/lab test), nursing considerations, treatment of overdose, patient/family teaching, and more. NEW! Updates on drug therapies provide the most current information.
LC Classification NumberRM301.12
